E-LIB Suche - Ergebnisse für: Jonathan Barratt

1

Effects of rare kidney diseases on kidney failure: a longit..:

Wong, Katie ; Pitcher, David ; Braddon, Fiona...
The Lancet. 403 (2024) 10433 - p. 1279-1289 , 2024

Link: https://doi.org/10.1016/..

2

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR P..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S174-S175 , 2024

Link: https://doi.org/10.1016/..

3

#368 Matching-Adjusted Indirect Comparisons of eGFR slopes ..:

Gong, Wu ; Diva, Ulysses ; Bensink, Mark...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

4

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLA..:

Trimarchi, Hernán ; Barratt, Jonathan ; Radhakrishnan, Jai...
Kidney International Reports. 9 (2024) 4 - p. S177 , 2024

Link: https://doi.org/10.1016/..

5

Hypoxia-inducible factor prolyl hydroxylase inhibitors for ..:

Stoumpos, Sokratis ; Crowe, Kirsty ; Sarafidis, Pantelis...
Nephrology Dialysis Transplantation. , 2024

Link: https://doi.org/10.1093/..

6

#812 Phase 2b ORIGIN study open label extension with atacic..:

Lafayette, Richard ; Maes, Bart ; Israni, Rubeen...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

7

WCN24-912 IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656,..:

Barratt, Jonathan ; Flöge, Jürgen ; Duggal, Vishal...
Kidney International Reports. 9 (2024) 4 - p. S147 , 2024

Link: https://doi.org/10.1016/..

8

WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGON..:

Tumlin, James ; Mandayam, Sreedhar ; Madan, Arvind...
Kidney International Reports. 9 (2024) 4 - p. S141 , 2024

Link: https://doi.org/10.1016/..

9

Unwelcome changes to the Specialised Foundation Programme r..:

Barratt, Jonathan ; Sharp, Debbie ; Dhillo, Waljit S.
The Lancet. 403 (2024) 10434 - p. 1333 , 2024

Link: https://doi.org/10.1016/..

10

Description and Cross-Sectional Analyses of 25,880 Adults a..:

Wong, Katie ; Pitcher, David ; Braddon, Fiona...
Kidney International Reports. , 2024

Link: https://doi.org/10.1016/..

11

#1342 Updated results from the RUBY-3 study of povetacicept..:

Madan, Arvind ; Park, Inwhee ; Yalavarthy, Rajesh...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

12

WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MON..:

Barratt, Jonathan ; Lafayette, Richard ; Suzuki, Hitoshi...
Kidney International Reports. 9 (2024) 4 - p. S125-S126 , 2024

Link: https://doi.org/10.1016/..

13

WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, B..:

Barratt, Jonathan ; Maes, Bart ; Lin, Celia...
Kidney International Reports. 9 (2024) 4 - p. S158 , 2024

Link: https://doi.org/10.1016/..

14

A phase 2b, randomized, double-blind, placebo-controlled, c..:

Lafayette, Richard ; Barbour, Sean ; Israni, Rubeen...
Kidney International. 105 (2024) 6 - p. 1306-1315 , 2024

Link: https://doi.org/10.1016/..

15

Targeted-release budesonide modifies key pathogenic biomark..:

Wimbury, David ; Muto, Masahiro ; Bhachu, Jasraj S....
Kidney International. 105 (2024) 2 - p. 381-388 , 2024

Link: https://doi.org/10.1016/..